463 related articles for article (PubMed ID: 19411391)
1. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
Reneses S; González-Escribano MF; Fernández-Suárez A; Pestana L; Davila B; Wichmann I; García A
J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391
[TBL] [Abstract][Full Text] [Related]
2. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
Kaltenhäuser S; Pierer M; Arnold S; Kamprad M; Baerwald C; Häntzschel H; Wagner U
Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
[TBL] [Abstract][Full Text] [Related]
4. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
5. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.
Quintana-Duque MA; Rondon-Herrera F; Mantilla RD; Calvo-Paramo E; Yunis JJ; Varela-Nariño A; Restrepo JF; Iglesias-Gamarra A
Clin Rheumatol; 2016 Jun; 35(6):1463-73. PubMed ID: 27041382
[TBL] [Abstract][Full Text] [Related]
6. Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.
Raslan HM; Attia HR; Salama I; Ibrahim MH; Hassan EM; El Hussieny MS; El Menyawi MM; Amr KS
Rheumatol Int; 2016 Aug; 36(8):1167-75. PubMed ID: 27324632
[TBL] [Abstract][Full Text] [Related]
7. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG
Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535
[TBL] [Abstract][Full Text] [Related]
8. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
9. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
Karlson EW; Chibnik LB; Cui J; Plenge RM; Glass RJ; Maher NE; Parker A; Roubenoff R; Izmailova E; Coblyn JS; Weinblatt ME; Shadick NA
Ann Rheum Dis; 2008 Mar; 67(3):358-63. PubMed ID: 17666451
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cumulative joint damage patterns in patients with rheumatoid arthritis: a clinical, serological, and gene polymorphism perspective.
Alarcon RT; Fernandes Ada R; Laurindo IM; Bértolo MB; Pinheiro GC; Andrade LE
J Rheumatol; 2015 Mar; 42(3):405-12. PubMed ID: 25641888
[TBL] [Abstract][Full Text] [Related]
11. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
Rojas-Villarraga A; Diaz FJ; Calvo-Páramo E; Salazar JC; Iglesias-Gamarra A; Mantilla RD; Anaya JM
J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
[TBL] [Abstract][Full Text] [Related]
12. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
[TBL] [Abstract][Full Text] [Related]
13. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.
Linn-Rasker SP; van der Helm-van Mil AH; van Gaalen FA; Kloppenburg M; de Vries RR; le Cessie S; Breedveld FC; Toes RE; Huizinga TW
Ann Rheum Dis; 2006 Mar; 65(3):366-71. PubMed ID: 16014670
[TBL] [Abstract][Full Text] [Related]
14. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B;
Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
[TBL] [Abstract][Full Text] [Related]
15. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
[TBL] [Abstract][Full Text] [Related]
16. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
17. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DP; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A;
Ann Rheum Dis; 2009 Jan; 68(1):69-74. PubMed ID: 18375541
[TBL] [Abstract][Full Text] [Related]
18. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.
Meyer O; Nicaise-Roland P; Santos MD; Labarre C; Dougados M; Goupille P; Cantagrel A; Sibilia J; Combe B
Arthritis Res Ther; 2006; 8(2):R40. PubMed ID: 16469118
[TBL] [Abstract][Full Text] [Related]
19. Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.
Montes A; Dieguez-Gonzalez R; Perez-Pampin E; Calaza M; Mera-Varela A; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2011 Mar; 63(3):654-61. PubMed ID: 21360494
[TBL] [Abstract][Full Text] [Related]
20. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]